HomeNewsBusinessStartupCompetition hots up, Groww goes live with stock trading

Competition hots up, Groww goes live with stock trading

The startup hopes to introduce futures and options and also intra-day trading over the next few months.

June 11, 2020 / 11:55 IST
Story continues below Advertisement

Bengaluru-based financial services platform Groww has gone live with stock trading, expanding its horizon beyond mutual funds and gold.

After testing the service for a few months, Groww recently opened it for its users, claiming to have already opened one lakh accounts. Moneycontrol was the first to write, on May 28, that Groww was beta testing a stock-trading platform.

Story continues below Advertisement

“We needed to get the broking licence then build the product which took some time. We have been doing internal testing since October 2019 and added more users in April this year. Now, we are opening it for others as well,” chief executive officer Lalit Keshre told Moneycontrol

Its users had been demand stock trading since 2018 and the company had been working on it for quite some time.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show